For the first time as a public company, Inogen Inc. (NASDAQ:INGN) reported fourth-quarter results after the close on Thursday, March 27. Revenue of $19.8 million was higher than our estimate of $18.6 million and the Street’s $18.5 million estimate. Inogen Inc. (NASDAQ:INGN) shares after opening at $14.75 moved to $14.75 on last trade day and at the end of the day closed at $14.64. Company price to sales ratio in past twelve months was calculated as 3.52 and price to cash ratio as 19.68. Inogen Inc. (NASDAQ:INGN) showed a negative weekly performance of -1.41%.
Derma Sciences, Inc. (NASDAQ:DSCI), a tissue regeneration company focused on advanced wound care, announces that its products are the subject of 10 poster presentations and abstracts to be featured at the Spring Symposium on Advanced Wound Care (SAWC). Derma Sciences also announces a new corporate branding campaign focused on driving awareness of the company’s leadership in tissue regeneration and wound healing. This campaign features a new corporate logo and the “A Tissue Regeneration Company” tagline, and will debut at the SAWC and at the 2014 MedAssets Healthcare Business Summit, two important conferences being held this week for clinicians dedicated to wound healing.Derma Sciences Inc. (NASDAQ:DSCI) shares fell -3.44% in last trading session and ended the day on $9.27. DSCI return on equity ratio is recorded as -28.40% and its return on assets is -25.10%. Derma Sciences Inc. (NASDAQ:DSCI) yearly performance is -18.33%.
BioTime, Inc. (NYSEMKT:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will present at the GTC Stem Cell Summit 2014 taking place April 23-25, 2014 in Cambridge, MA.
BioTime, Inc. (NYSEMKT:BTX) shares moved down -7.38% in last trading session and was closed at $2.51, while trading in range of $2.51 – $2.71. BioTime, Inc. (NYSEMKT:BTX) year to date (YTD) performance is -30.28%.
On March 7, 2014, the Board of Directors of Verastem, Inc. (NASDAQ:VTSM) unanimously voted to increase the size of the Company’s Board of Directors. Verastem Inc. (NASDAQ:VSTM) weekly performance is -11.81%. On last trading day company shares ended up $7.84. Verastem Inc. (NASDAQ:VSTM) distance from 50-day simple moving average (SMA50) is -35.10%. Analysts mean target price for the company is $22.56.